PHARMA-BIO SERV, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
PHARMA-BIO SERV, INC. (PBSV) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $10.00 thousand for the 3-month period ending 2025-07-31, per its 10-Q filed 2025-09-15.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2025-09-15
- PHARMA-BIO SERV, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-07-31 was $10.00K, a 32.44% decline year-over-year.
- PHARMA-BIO SERV, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-04-30 was $10.00K, a 32.43% decline year-over-year.
- PHARMA-BIO SERV, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-07-31 was $14.80K.
- PHARMA-BIO SERV, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-04-30 was $14.80K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month |
|---|---|---|---|
| 2025-07-31 | $10.00K 10-Q · filed 2025-09-15 | $20.00K derived: sum of 2 quarters · filed 2025-09-15 | $30.68K 10-Q · filed 2025-09-15 |
| 2025-04-30 | $10.00K 10-Q · filed 2025-06-16 | $20.68K 10-Q · filed 2025-06-16 | |
| 2024-07-31 | $14.80K 10-Q · filed 2025-09-15 | $29.60K derived: sum of 2 quarters · filed 2025-09-15 | $44.40K 10-Q · filed 2025-09-15 |
| 2024-04-30 | $14.80K 10-Q · filed 2025-06-16 | $29.60K 10-Q · filed 2025-06-16 |